Measuring DNA hybridization using fluorescent DNA-stabilized silver clusters to investigate mismatch effects on therapeutic oligonucleotides
de Bruin D, Bossert N, Aartsma-Rus A, Bouwmeester D. J Nanobiotechnology. 2018 Apr 6;16(1):37. PubMed
RNA-Targeted Therapeutics
Crooke ST, Witztum JL, Bennett CF, Baker BF. Cell Metab. 2018 Apr 3;27(4):714-739. PubMed
Aptamer chemistry
Röthlisberger P, Hollenstein M. Adv Drug Deliv Rev. 2018 Apr 4. PubMed
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Urbanski LM, Leclair N, AnczukĂ³w O. Wiley Interdiscip Rev RNA. 2018 Apr 25:e1476. PubMed
Nucleic acids delivering nucleic acids
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Adv Drug Deliv Rev. 2018 Apr 6. pii: S0169-409X(18)30058-9 PubMed
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Miniarikova J, Evers MM, Konstantinova P. Mol Ther. 2018 Apr 4;26(4):947-962. PubMed
Basics of intellectual property and patenting
Presenter: Laurence Gainey, PhD, HGF Intellectual Property Specialists Date: May 24th 2018 Description: This webinar will be a short, basic introduction to the process of patenting as it applies to biotherapeutics, including some territorial differences. It will cover the core requirements for a patent ...